Developer docs
API playgroundTry for free, no card

Search company profiles

Calpol

Full company profile

uuid00332of

Namestring
Calpol
Legal namestring
Kenvue UK Limited
Websiteurl
calpol.co.uk
Company typeenum
Private
Founded yearint
1970
Descriptiontext

Calpol is the UK's leading over-the-counter children's medicine brand, operating as a brand within Kenvue UK Limited (registered in Reading, UK), a subsidiary of NYSE-listed Kenvue Inc. which spun off from Johnson & Johnson in November 2023. The portfolio spans age-specific paracetamol suspensions (Infant Suspension for 2 months–6 years; SixPlus Suspension and Fastmelts for 6+ years), an ibuprofen suspension (CALPROFEN, 3 months+), cough syrups (CALCOUGH Infant and Children's, glycerol-based), a teething gel (CALGEL, lidocaine + cetylpyridinium chloride, 5 months+), saline and salt-solution nasal sprays/drops, and a non-medicinal vapour plug device with nightlight. Products are formulated for precise age-banded dosing and include MHRA-compliant dosing syringes, with strawberry, blackcurrant, and apple flavouring to support pediatric administration. Each SKU carries a registered UK/EU trademark (CALPOL, CALPROFEN, CALGEL, CALCOUGH, SIXPLUS).

Calpol distributes through a multi-channel UK retail footprint covering the five largest supermarket chains (Tesco, Sainsbury's, Morrisons, Waitrose, ASDA), pharmacy retailers (Boots, LloydsPharmacy, Superdrug, Chemist4U, Weldricks, Pharmacy2U), and online marketplaces (Amazon, Ocado). Revenue is generated through one-time unit-based retail sales of branded OTC medicines and adjacent non-medicinal devices, with no subscription component. The primary customer segment is parents and caregivers of children aged 0–12 in the UK, with sub-segments further defined by age (infants, toddlers, young children, older children), each addressed by formulation-specific SKUs. Marketing combines an educational content hub on calpol.co.uk, healthcare professional endorsement (paediatric nurse Dawn Kelly), and a social-purpose partnership with the NSPCC, all reinforcing brand trust rather than driving direct-response conversion. Calpol UK is the #1 selling children's medicine brand in the UK by value and units (NielsenIQ 2025, Total Paediatrics Category), with 9 out of 10 surveyed parents recommending the brand, and the operating geography is explicitly restricted to UK residents.

Short descriptiontext

Calpol is the UK's #1 selling children's OTC medicine brand (Kenvue UK Limited), selling paracetamol and ibuprofen suspensions, cough syrups, teething gel, nasal sprays, and a vapour plug device to UK parents of children aged 0–12 through supermarkets, pharmacies, and online retailers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersKortemark, Belgium
HQ citystring
Kortemark
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pediatric OTC medicines, children's paracetamol suspensions, infant ibuprofen syrup, teething and fever relief, kids cough and congestion
Product category
Pediatric OTC Medicines
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1OTC Children's Medicines Retail Sales
TypeOne Time License
Description

Calpol generates revenue through sale of branded OTC medicines and non-medicinal healthcare products for children. Products are distributed through retail channels including supermarkets, pharmacies, and online marketplaces. Revenue is one-time purchase based with no subscription component, though repeat purchases occur during childhood illness episodes.

calpol.co.uk
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Marketing or Sales, Operations, Personnel, Technology or R&D
Pricing details5 tiers
1Infant Suspension (2 months - 6 years)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Available in Original Strawberry Flavour (100ml, 200ml), Sugar Free Strawberry Flavour (100ml, 200ml), Sugar Free Colour Free (100ml), and Sugar Free Sachets (12 x 5ml). Specific retail pricing not disclosed on website.

calpol.co.uk
2SixPlus Oral Suspension and Fastmelts (6+ years)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

SixPlus Suspension available as Sugar Free Strawberry Flavour (80ml, 100ml, 200ml) and Sachets (12x 5ml). Fastmelts available in 12-count and 24-count packages. Specific retail pricing not disclosed on website.

calpol.co.uk
3CALPROFEN Ibuprofen Suspension (3 months - 12 years)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Strawberry flavour oral suspension. Available sizes and specific retail pricing not disclosed on website.

calpol.co.uk
4CALGEL Teething Gel (5+ months)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

10g tube containing lidocaine hydrochloride and cetylpyridinium chloride. Specific retail pricing not disclosed on website.

calpol.co.uk
5Vapour Plug & Nightlight (3+ months)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Refill pads available in 5-pack and 10-pack options. Non-medicinal product. Specific retail pricing not disclosed on website.

calpol.co.uk
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1CALPROFEN
Description

Ibuprofen oral suspension for pain and fever relief in infants and children from 3 months

calpol.co.uk
+3 more records
Core offering1 text field

Calpol develops and sells a branded range of over-the-counter medicines and non-medicinal healthcare products for children from birth through 12+ years. The portfolio includes paracetamol suspensions (Infant Suspension 2 months to 6 years and SixPlus 6+ years), ibuprofen suspension (Calprofen), cough syrups (Calcough Infant and Children's), teething gel with anaesthetic (Calgel), saline and salt-solution nasal sprays, and a vapour plug device with nightlight. Products are formulated with age-appropriate dosing and child-friendly flavors and are distributed through UK supermarkets, pharmacies, and online marketplaces.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 9 out of 10 parents recommend Calpol for fast effective pain and fever relief (J&J Survey 2023, n=291/302 parents with children aged 6 months to 12 years)
+2 more records
Product overview1 text field

Calpol is a pharmaceutical/OTC medicine brand specializing in children's healthcare products. The portfolio consists of paracetamol-based products (Infant Suspension for 2 months to 6 years, SixPlus Suspension and Fastmelts for 6+ years), ibuprofen-based CALPROFEN, cough syrups (CALCOUGH Infant and Children's), teething gel (CALGEL), nasal sprays (Blocked Nose Spray and Saline Spray/Drops), and the Vapour Plug & Nightlight device. The products target infants and children from birth through 12 years, addressing common childhood ailments including fever, pain, cough, cold, congestion, and teething.

Product and service10 records
1Calpol Infant Sugar Free Suspension
CategoryPediatric OTC Analgesic / Antipyretic
Description

Paracetamol-based oral suspension for babies and children aged 2 months to 6 years, providing relief from pain and fever; formulated to start working on fever in 15 minutes and supplied with a precision dosing syringe.

2Calpol SixPlus Oral Suspension Paracetamol for Children
CategoryPediatric OTC Analgesic / Antipyretic
Description

Paracetamol-based oral suspension with over twice the strength of Infant Suspension, formulated for children aged 6 years and over for pain and fever relief.

3Calpol SixPlus Fastmelts
CategoryPediatric OTC Analgesic / Antipyretic
Description

Strawberry-flavoured dissolve-in-the-mouth tablets for children 6 years and over, providing on-the-go pain and fever relief without the need for water.

4Calprofen Ibuprofen Oral Suspension
CategoryPediatric OTC NSAID
Description

Ibuprofen-based strawberry-flavoured oral suspension for infants from 3 months, providing pain and fever relief as an alternative to paracetamol.

5Calcough Infant Syrup
CategoryPediatric Cough Syrup
Description

Glycerol-based apple-flavoured cough syrup for babies and toddlers aged 3 months to 5 years, soothing and relieving dry, tickly coughs.

6Calcough Children's Syrup
CategoryPediatric Cough Syrup
Description

Blackcurrant-flavoured cough syrup with glycerol and liquid sugar for children aged 1 year and above, providing relief from dry, tickly coughs and sore throats.

7Calgel Teething Gel for Babies
CategoryPediatric Teething Treatment
Description

Sugar-free teething gel containing lidocaine hydrochloride (local anaesthetic) and cetylpyridinium chloride (antiseptic) for babies 5 months and over, providing rapid relief from teething pain.

8Calpol Blocked Nose Spray
CategoryPediatric Nasal Care
Description

Salt-solution nasal spray for children over 3 years and adults, providing relief from nasal congestion caused by colds, flu, sinusitis, and allergies including hay fever.

9Calpol Saline Nasal Spray & Drops
CategoryPediatric Nasal Care
Description

Non-medicated saline nasal spray and drops suitable from birth, designed to wash away built-up mucus and relieve nasal congestion in babies and young children.

10Calpol Vapour Plug & Nightlight with Refill Pads
CategoryPediatric Non-Medicinal Healthcare Device
Description

Plug-in vapour device with lavender and chamomile refill pads (5-pack and 10-pack) that release aromatic vapours for up to 8 hours and provide a soft nightlight glow for children from 3 months, supporting comfortable breathing and sleep.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Calpol has partnered with the NSPCC (National Society for the Prevention of Cruelty to Children) to help give children a brighter future. The partnership aims to support the NSPCC's work in protecting children and providing them with safer futures. The Calpol website includes information about the partnership with a call-to-action for consumers to find out more and donate.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Procter & Gamble's respiratory care brand including Vicks BabyRub and VapoRub. Overlaps with Calpol's Vapour Plug and cough range for parents seeking non-oral comfort and relief for children during colds.

TypeBroad incumbent
Description

Kenvue / Johnson & Johnson's decongestant brand. A sibling brand within Kenvue's UK portfolio and a partial substitute for Calpol's Blocked Nose Spray and Saline Nasal Spray range in the paediatric congestion segment.

3Lemsip
TypeDirect peer
Description

Reckitt Benckiser's UK cold and flu remedy brand. Shares Calpol's supermarket and pharmacy distribution and competes for parents seeking symptomatic relief for children with coughs and congestion.

4Piriton
TypeDirect peer
Description

Haleon's UK children's allergy syrup brand. Competes with Calpol in the paediatric OTC space across UK pharmacies and supermarkets for childhood allergy and symptomatic relief.

TypeEmerging player
Description

Haleon's naturals-leaning paediatric cough and immune support brand. Targets the same parents of young children with syrups and gummies, increasingly competing on shelf space and natural-ingredient positioning.

6Nurofen for Children
TypeDirect peer
Description

Reckitt Benckiser's paediatric ibuprofen range, directly comparable to Calpol's Calprofen. Competes head-to-head on the same UK supermarket and pharmacy shelves for parents seeking ibuprofen-based fever and pain relief.

TypeBroad incumbent
Description

Consumer health major spun off from GSK in 2022, owning Panadol, Piriton, Centrum and Sensodyne. Operates across the same UK retail channels as Calpol and competes via multiple paediatric and adult OTC brands.

TypeDirect peer
Description

Johnson & Johnson / Kenvue's paediatric allergy brand, historically sister to Calpol within the same parent group. Targets the same parents for childhood allergy and cold symptoms through overlapping UK retail distribution.

TypeDirect peer
Description

Johnson & Johnson's flagship paracetamol brand and Calpol's US equivalent in terms of consumer positioning and category leadership. Same active ingredient, same paediatric focus, and historically sister brand within the same J&J consumer health organisation.

10Children's Panadol
TypeDirect peer
Description

Haleon's flagship paediatric paracetamol brand and Calpol's most direct competitor in the UK and global markets. Targets the same parents of infants and young children for fever and pain relief with age-tiered formulations.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Calpol

Pediatric OTC Medicinescalpol.co.uk

Calpol is the UK's #1 selling children's OTC medicine brand (Kenvue UK Limited), selling paracetamol and ibuprofen suspensions, cough syrups, teething gel, nasal sprays, and a vapour plug device to UK parents of children aged 0–12 through supermarkets, pharmacies, and online retailers.

What Calpol does

Calpol is the UK's leading over-the-counter children's medicine brand, operating as a brand within Kenvue UK Limited (registered in Reading, UK), a subsidiary of NYSE-listed Kenvue Inc. which spun off from Johnson & Johnson in November 2023. The portfolio spans age-specific paracetamol suspensions (Infant Suspension for 2 months–6 years; SixPlus Suspension and Fastmelts for 6+ years), an ibuprofen suspension (CALPROFEN, 3 months+), cough syrups (CALCOUGH Infant and Children's, glycerol-based), a teething gel (CALGEL, lidocaine + cetylpyridinium chloride, 5 months+), saline and salt-solution nasal sprays/drops, and a non-medicinal vapour plug device with nightlight. Products are formulated for precise age-banded dosing and include MHRA-compliant dosing syringes, with strawberry, blackcurrant, and apple flavouring to support pediatric administration. Each SKU carries a registered UK/EU trademark (CALPOL, CALPROFEN, CALGEL, CALCOUGH, SIXPLUS).

Calpol distributes through a multi-channel UK retail footprint covering the five largest supermarket chains (Tesco, Sainsbury's, Morrisons, Waitrose, ASDA), pharmacy retailers (Boots, LloydsPharmacy, Superdrug, Chemist4U, Weldricks, Pharmacy2U), and online marketplaces (Amazon, Ocado). Revenue is generated through one-time unit-based retail sales of branded OTC medicines and adjacent non-medicinal devices, with no subscription component. The primary customer segment is parents and caregivers of children aged 0–12 in the UK, with sub-segments further defined by age (infants, toddlers, young children, older children), each addressed by formulation-specific SKUs. Marketing combines an educational content hub on calpol.co.uk, healthcare professional endorsement (paediatric nurse Dawn Kelly), and a social-purpose partnership with the NSPCC, all reinforcing brand trust rather than driving direct-response conversion. Calpol UK is the #1 selling children's medicine brand in the UK by value and units (NielsenIQ 2025, Total Paediatrics Category), with 9 out of 10 surveyed parents recommending the brand, and the operating geography is explicitly restricted to UK residents.

Calpol firmographics

Firmographics
Name
Calpol
Legal name
Kenvue UK Limited
Website
https://calpol.co.uk
Company type
Private
Founded year
1970
Operating status
Operating
Headcount range
1–10 employees
Short description
Calpol is the UK's #1 selling children's OTC medicine brand (Kenvue UK Limited), selling paracetamol and ibuprofen suspensions, cough syrups, teething gel, nasal sprays, and a vapour plug device to UK parents of children aged 0–12 through supermarkets, pharmacies, and online retailers.
Ownership category
akta.pro rank

Where Calpol is headquartered

Location

Headquarters

HQ city
Kortemark
HQ country
Belgium
HQ region
Europe

Offices1 record

Markets served

Calpol business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Marketing or Sales, Operations, Personnel, Technology or R&D

Revenue model

  1. OTC Children's Medicines Retail Sales: Calpol generates revenue through sale of branded OTC medicines and non-medicinal healthcare products for children. Products are distributed through retail channels including supermarkets, pharmacies, and online marketplaces. Revenue is one-time purchase based with no subscription component, though repeat purchases occur during childhood illness episodes.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goInfant Suspension (2 months - 6 years)
Unit PricingPay-as-you-goSixPlus Oral Suspension and Fastmelts (6+ years)
Unit PricingPay-as-you-goCALPROFEN Ibuprofen Suspension (3 months - 12 years)
Unit PricingPay-as-you-goCALGEL Teething Gel (5+ months)
Unit PricingPay-as-you-goVapour Plug & Nightlight (3+ months)

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Calpol product offering

Product offering

Core offering

Calpol develops and sells a branded range of over-the-counter medicines and non-medicinal healthcare products for children from birth through 12+ years. The portfolio includes paracetamol suspensions (Infant Suspension 2 months to 6 years and SixPlus 6+ years), ibuprofen suspension (Calprofen), cough syrups (Calcough Infant and Children's), teething gel with anaesthetic (Calgel), saline and salt-solution nasal sprays, and a vapour plug device with nightlight. Products are formulated with age-appropriate dosing and child-friendly flavors and are distributed through UK supermarkets, pharmacies, and online marketplaces.

Product overview

Calpol is a pharmaceutical/OTC medicine brand specializing in children's healthcare products. The portfolio consists of paracetamol-based products (Infant Suspension for 2 months to 6 years, SixPlus Suspension and Fastmelts for 6+ years), ibuprofen-based CALPROFEN, cough syrups (CALCOUGH Infant and Children's), teething gel (CALGEL), nasal sprays (Blocked Nose Spray and Saline Spray/Drops), and the Vapour Plug & Nightlight device. The products target infants and children from birth through 12 years, addressing common childhood ailments including fever, pain, cough, cold, congestion, and teething.

Differentiator

Problem solved

Functional benefit

Brands

  • CALPROFEN: Ibuprofen oral suspension for pain and fever relief in infants and children from 3 months
  • CALGEL
  • CALCOUGH
  • SIXPLUS

Products and services

  • Calpol Infant Sugar Free Suspension Paracetamol-based oral suspension for babies and children aged 2 months to 6 years, providing relief from pain and fever; formulated to start working on fever in 15 minutes and supplied with a precision dosing syringe.
  • Calpol SixPlus Oral Suspension Paracetamol for Children Paracetamol-based oral suspension with over twice the strength of Infant Suspension, formulated for children aged 6 years and over for pain and fever relief.
  • Calpol SixPlus Fastmelts Strawberry-flavoured dissolve-in-the-mouth tablets for children 6 years and over, providing on-the-go pain and fever relief without the need for water.
  • Calprofen Ibuprofen Oral Suspension Ibuprofen-based strawberry-flavoured oral suspension for infants from 3 months, providing pain and fever relief as an alternative to paracetamol.
  • Calcough Infant Syrup Glycerol-based apple-flavoured cough syrup for babies and toddlers aged 3 months to 5 years, soothing and relieving dry, tickly coughs.
  • Calcough Children's Syrup Blackcurrant-flavoured cough syrup with glycerol and liquid sugar for children aged 1 year and above, providing relief from dry, tickly coughs and sore throats.
  • Calgel Teething Gel for Babies Sugar-free teething gel containing lidocaine hydrochloride (local anaesthetic) and cetylpyridinium chloride (antiseptic) for babies 5 months and over, providing rapid relief from teething pain.
  • Calpol Blocked Nose Spray Salt-solution nasal spray for children over 3 years and adults, providing relief from nasal congestion caused by colds, flu, sinusitis, and allergies including hay fever.
  • Calpol Saline Nasal Spray & Drops Non-medicated saline nasal spray and drops suitable from birth, designed to wash away built-up mucus and relieve nasal congestion in babies and young children.
  • Calpol Vapour Plug & Nightlight with Refill Pads Plug-in vapour device with lavender and chamomile refill pads (5-pack and 10-pack) that release aromatic vapours for up to 8 hours and provide a soft nightlight glow for children from 3 months, supporting comfortable breathing and sleep.

Quantifiable outcome

  • 9 out of 10 parents recommend Calpol for fast effective pain and fever relief (J&J Survey 2023, n=291/302 parents with children aged 6 months to 12 years)
  • +2 more outcomes

Companies that use Calpol

Customer profile

Segments2 records

Ideal customer profiles1 record

Calpol technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Calpol partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • NSPCCcoreStrategic or Co-development PartnerCalpol has partnered with the NSPCC (National Society for the Prevention of Cruelty to Children) to help give children a brighter future. The partnership aims to support the NSPCC's work in protecting children and providing them with safer futures. The Calpol website includes information about the partnership with a call-to-action for consumers to find out more and donate.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Calpol competitors and assessment

Company assessment

Emerging players

  • Vicks: Procter & Gamble's respiratory care brand including Vicks BabyRub and VapoRub. Overlaps with Calpol's Vapour Plug and cough range for parents seeking non-oral comfort and relief for children during colds.
  • Zarbee's Naturals: Haleon's naturals-leaning paediatric cough and immune support brand. Targets the same parents of young children with syrups and gummies, increasingly competing on shelf space and natural-ingredient positioning.

Broad incumbents

  • Sudafed: Kenvue / Johnson & Johnson's decongestant brand. A sibling brand within Kenvue's UK portfolio and a partial substitute for Calpol's Blocked Nose Spray and Saline Nasal Spray range in the paediatric congestion segment.
  • Haleon: Consumer health major spun off from GSK in 2022, owning Panadol, Piriton, Centrum and Sensodyne. Operates across the same UK retail channels as Calpol and competes via multiple paediatric and adult OTC brands.

Direct peers

  • Lemsip: Reckitt Benckiser's UK cold and flu remedy brand. Shares Calpol's supermarket and pharmacy distribution and competes for parents seeking symptomatic relief for children with coughs and congestion.
  • Piriton: Haleon's UK children's allergy syrup brand. Competes with Calpol in the paediatric OTC space across UK pharmacies and supermarkets for childhood allergy and symptomatic relief.
  • Nurofen for Children: Reckitt Benckiser's paediatric ibuprofen range, directly comparable to Calpol's Calprofen. Competes head-to-head on the same UK supermarket and pharmacy shelves for parents seeking ibuprofen-based fever and pain relief.
  • Benadryl Allergy Children's: Johnson & Johnson / Kenvue's paediatric allergy brand, historically sister to Calpol within the same parent group. Targets the same parents for childhood allergy and cold symptoms through overlapping UK retail distribution.
  • Tylenol: Johnson & Johnson's flagship paracetamol brand and Calpol's US equivalent in terms of consumer positioning and category leadership. Same active ingredient, same paediatric focus, and historically sister brand within the same J&J consumer health organisation.
  • Children's Panadol: Haleon's flagship paediatric paracetamol brand and Calpol's most direct competitor in the UK and global markets. Targets the same parents of infants and young children for fever and pain relief with age-tiered formulations.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Calpol social profiles

Digital presence

Calpol financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Calpol leadership team

Management profile

Number of profiles

Calpol funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Calpol M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Calpol

What does Calpol do?

Calpol develops and sells a branded range of over-the-counter medicines and non-medicinal healthcare products for children from birth through 12+ years. The portfolio includes paracetamol suspensions (Infant Suspension 2 months to 6 years and SixPlus 6+ years), ibuprofen suspension (Calprofen), cough syrups (Calcough Infant and Children's), teething gel with anaesthetic (Calgel), saline and salt-solution nasal sprays, and a vapour plug device with nightlight. Products are formulated with age-appropriate dosing and child-friendly flavors and are distributed through UK supermarkets, pharmacies, and online marketplaces.

Is Calpol a public or private company?

Calpol is a private company. It is classified as corporate owned and is currently operating.

When was Calpol founded?

Calpol was founded in 1970. It employs 1 to 10 people.

Where is Calpol based?

Calpol is headquartered in Kortemark, Belgium, in the Europe region.

How does Calpol make money?

One revenue line is on record: OTC Children's Medicines Retail Sales.

Who are Calpol's main competitors?

Emerging players on record are Vicks and Zarbee's Naturals. Broad incumbents are Sudafed and Haleon. Direct peers are Lemsip, Piriton, Nurofen for Children, Benadryl Allergy Children's, Tylenol and Children's Panadol.

Does Calpol have an API?

No public API is recorded for Calpol.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals